MARISSA DUPLAGA: Open Payments
NPI 1871060343 · WHEELING, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$514 in 30 payments from 11 companies in 2025. Trend: 2023 $1,581 · 2024 $1,289 · 2025 $514
Food & beverage: $514
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $113 |
| Astellas Pharma US Inc | 4 | $76 |
| Kowa Pharmaceuticals America, Inc. | 5 | $73 |
| Novo Nordisk Inc | 4 | $65 |
| PFIZER INC. | 3 | $49 |
| Lundbeck LLC | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
| Optinose US, Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: BRILINTA, Veozah, ZORYVE, Ozempic, Xhance, REXULTI, ELIQUIS, VOQUEZNA.
Industry payments across WV — which companies pay providers there.
